NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-174-2018-2-CH-01 TUMOR INFILTRATING LYMPHOCYTES AND METHODS OF THERAPY CH EP 17861792.4 Issued
NCI E-174-2018-2-JP-08 CAS9 Modified TILS For Treatment Of Gastrointestinal Cancer JP National Stage 2019-520738 Issued
NCI E-174-2018-2-AU-04 CAS9 Modified TILS For Treatment Of Gastrointestinal Cancer AU National Stage 2017346885 Issued
NCI E-174-2018-2-GB-03 CAS9 Modified TILS For Treatment Of Gastrointestinal Cancer GB National Stage 1906855.0 Issued
NCI E-289-2011-0-AU-20 YEAST-MUC1 IMMUNOTHERAPY COMPOSITIONS AND USES THEREOF AU DIV 2017248462 Issued
NCI E-495-2013-0-US-09 ANTI-HUMAN PAPILLOMAVIRUS 16 E6 T CELL RECEPTORS US CON 15/786,966 10329339 Issued PDF
NCI E-174-2018-2-PCT-01 CAS9 Modified TILS For Treatment Of Gastrointestinal Cancer PCT PCT COMB PCT/US2017/057228 Expired
NCI E-174-2018-2-CN-06 CAS9 Modified TILS For Treatment Of Gastrointestinal Cancer CN National Stage 201780078471.6 Pending
NCI E-174-2018-2-CA-05 CAS9 Modified TILS For Treatment Of Gastrointestinal Cancer CA National Stage 3041068 Abandoned
NCI E-149-2015-0-US-05 METHODS OF ISOLATING T CELLS AND T CELL RECEPTORS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION FROM PERIPHERAL BLOOD US National Stage 15/567,157 10544392 Issued PDF
NIAID E-101-2018-0-PCT-02 Multi-Specific Antibodies Targeting Human Immunodeficiency Virus And Methods Of Using The Same PCT PCT PCT/US2017/057053 Expired
NIDCR E-160-2000-1-US-10 T2R, A NOVEL FAMILY OF TASTE RECEPTORS US DIV 15/786,468 Abandoned
NIAID E-101-2018-0-EP-03 Multi-Specific Antibodies Targeting Human Immunodeficiency Virus And Methods Of Using The Same EP National Stage 17862065.4 Pending
NCI E-033-2013-1-US-05 STABILIZED SINGLE HUMAN CD4 DOMAINS AND FUSION PROTEINS US CON 15/784,988 10647754 Issued PDF
NCI E-014-2018-0-US-01 Compositions and Methods For Treating Cancer With Anti-CD22 Immunotherapy US 62/572,926 Abandoned
NIAID E-240-2017-0-US-01 RECOMBINANT HIV-1 ENVELOPE PROTEINS AND THEIR USE US 62/572,973 Abandoned
NCI E-097-2017-0-US-01 Macromolecular Platform For Targeting Scavenger Receptor A1 US 62/572,733 Abandoned
NCATS E-091-2016-0-IN-06 METHOD OF BLOCKING TRANSMISSION OF MALARIAL PARASITE IN National Stage 201917014688 Issued
NIMH E-448-2013-0-US-05 Antineuronal Antibodies In Pediatric Acute Neurologic Syndrome For Diagnosis And Treatment US CON 15/783,541 10228376 Issued PDF
NCATS E-091-2016-0-PCT-02 METHOD OF BLOCKING TRANSMISSION OF MALARIAL PARASITE PCT PCT PCT/US2017/056619 Expired
NCATS E-091-2016-0-EP-05 COMPOUNDS AND METHOD FOR BLOCKING TRANSMISSION OF MALARIAL PARASITE EP National Stage 17797478.9 Pending
NHGRI E-007-1999-2-JP-12 Cellular Arrays and Methods of Detecting and Using Genetic Disorder Markers JP DIV 2017-199639 Expired
NCATS E-091-2016-0-BR-03 COMPOUNDS AND METHOD FOR BLOCKING TRANSMISSION OF
MALARIAL PARASITE 		BR National Stage BR1120190075941 Pending
NIDDK E-254-2017-0-US-01 INHIBITORS TARGETING THE P51-P66 INTERFACIAL CAVITY OF HIV-1 RT US 62/571,662 Abandoned
NHLBI E-183-2018-0-US-01 3D Bioprinting Of Cardiac Patch With Anisotropic And Perfusable Architecture US 62/571,684 Abandoned
NCI E-276-2016-0-AU-03 HPPK INHIBITORS USEFUL AS ANTIBACTERIAL AGENTS AU National Stage 2017343643 Issued
NEI E-050-2015-0-EP-06 RP2 and RPGR Vectors for Treating X-Linked Retinitis Pigmentosa EP National Stage 16762623.3 Issued
NEI E-050-2015-0-GB-12 RP2 and RPGR Vectors for Treating X-Linked Retinitis Pigmentosa GB EP 16762623.3 Issued
NEI E-050-2015-0-DE-10 RP2 and RPGR Vectors for Treating X-Linked Retinitis Pigmentosa DE EP 16762623.3 Issued
NEI E-050-2015-0-FR-11 RP2 and RPGR Vectors for Treating X-Linked Retinitis Pigmentosa FR EP 16762623.3 Issued
NIAID E-257-2016-0-PCT-02 TREATMENT OF TUMORS BY INHIBITION OF CD300F PCT PCT PCT/US2017/056192 Expired
NCI E-276-2016-0-PCT-02 HPPK INHIBITORS USEFUL AS ANTIBACTERIAL AGENTS PCT PCT PCT/US2017/056124 Expired
NCI E-002-2018-0-US-01 METHODS OF PRODUCING T CELL POPULATIONS USING P38 MAPK INHIBITORS US 62/570,708 Abandoned
NCI E-276-2016-0-CA-04 HPPK INHIBITORS USEFUL AS ANTIBACTERIAL AGENTS CA National Stage 3039997 Pending
NCATS E-115-2018-0-US-01 EMETINE COMPOUNDS FOR TREATMENT AND PREVENTION OF FLAVIVIRUS INFECTION US 62/570,553 Abandoned
NCI E-254-2005-2-US-25 CODON OPTIMIZED IL-15 AND IL-15R-ALPHA GENES FOR EXPRESSION IN MAMMALIAN CELLS US DIV 15/728,455 10428133 Issued PDF
NHLBI E-194-2015-0-US-04 Imaging Systems And Methods Using Floursecent Nanodiamonds US National Stage 15/565,123 10627340 Issued PDF
NHGRI E-044-2013-0-US-07 METHODS FOR TREATING PROGEROID LAMINOPATHIES USING OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA US CON 15/727,483 10398721 Issued PDF
NLM E-107-2010-2-US-15 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US CON 15/725,917 1073-12-04 Issued PDF
NCI E-182-2017-0-US-01 METHODS FOR SELECTIVELY EXPANDING CELLS EXPRESSING A TCR WITH A MURINE CONSTANT REGION US 62/568,339 Abandoned
NIAID E-086-2018-2-US-01 Zika Viral Antigen Constructs US 62/568,559 Abandoned
NIMH E-206-2017-0-US-01 Systems and Methods for Probing In Vivo Metabolite Relaxation by Linear Quantification of Spatially Modulated Magnetization US 62/567,991 Abandoned
NIBIB E-150-2016-1-HK-07 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS HK EP 62020015610.2 Issued
NIBIB E-150-2016-1-IE-01 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS IE EP 17928082.1 Issued
NIBIB E-150-2016-1-FR-01 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS FR EP 17928082.1 Issued
NIBIB E-150-2016-1-DE-01 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS DE EP 17928082.1 Issued
NIBIB E-150-2016-1-EP-03 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS EP National Stage 17928082.1 Issued
NIBIB E-150-2016-1-GB-01 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS GB EP 17928082.1 Issued
NIBIB E-150-2016-1-CH-01 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS CH EP 17928082.1 Issued
NIBIB E-150-2016-1-CN-02 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS CN National Stage 201780095506.7 Issued